These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 31301338

  • 1. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
    Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
    J Control Release; 2019 Aug 28; 308():1-13. PubMed ID: 31301338
    [Abstract] [Full Text] [Related]

  • 2. In vitro-in vivo correlation of parenteral PLGA microspheres: Effect of variable burst release.
    Andhariya JV, Jog R, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
    J Control Release; 2019 Nov 28; 314():25-37. PubMed ID: 31654687
    [Abstract] [Full Text] [Related]

  • 3. Polymer source affects in vitro-in vivo correlation of leuprolide acetate PLGA microspheres.
    Wan B, Bao Q, Wang R, Burgess DJ.
    Int J Pharm; 2022 Sep 25; 625():122032. PubMed ID: 35878870
    [Abstract] [Full Text] [Related]

  • 4. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
    Zhou J, Walker J, Ackermann R, Olsen K, Hong JKY, Wang Y, Schwendeman SP.
    Mol Pharm; 2020 May 04; 17(5):1502-1515. PubMed ID: 32074448
    [Abstract] [Full Text] [Related]

  • 5. Reverse Engineering the 1-Month Lupron Depot®.
    Zhou J, Hirota K, Ackermann R, Walker J, Wang Y, Choi S, Schwendeman A, Schwendeman SP.
    AAPS J; 2018 Oct 02; 20(6):105. PubMed ID: 30280294
    [Abstract] [Full Text] [Related]

  • 6. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature.
    Wan B, Bao Q, Burgess DJ.
    J Control Release; 2022 Jul 02; 347():347-355. PubMed ID: 35569590
    [Abstract] [Full Text] [Related]

  • 7. Mechanistic evaluation of the initial burst release of leuprolide from spray-dried PLGA microspheres.
    Schutzman R, Shi NQ, Olsen KF, Ackermann R, Tang J, Liu YY, Hong JKY, Wang Y, Qin B, Schwendeman A, Schwendeman SP.
    J Control Release; 2023 Sep 02; 361():297-313. PubMed ID: 37343723
    [Abstract] [Full Text] [Related]

  • 8. Development of in vitro-in vivo correlation of parenteral naltrexone loaded polymeric microspheres.
    Andhariya JV, Shen J, Choi S, Wang Y, Zou Y, Burgess DJ.
    J Control Release; 2017 Jun 10; 255():27-35. PubMed ID: 28385676
    [Abstract] [Full Text] [Related]

  • 9. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
    Shen J, Choi S, Qu W, Wang Y, Burgess DJ.
    J Control Release; 2015 Nov 28; 218():2-12. PubMed ID: 26423236
    [Abstract] [Full Text] [Related]

  • 10. Effect of polymer source on in vitro drug release from PLGA microspheres.
    Wan B, Andhariya JV, Bao Q, Wang Y, Zou Y, Burgess DJ.
    Int J Pharm; 2021 Sep 25; 607():120907. PubMed ID: 34332059
    [Abstract] [Full Text] [Related]

  • 11. Influence of PLGA molecular weight distribution on leuprolide release from microspheres.
    Ochi M, Wan B, Bao Q, Burgess DJ.
    Int J Pharm; 2021 Apr 15; 599():120450. PubMed ID: 33675924
    [Abstract] [Full Text] [Related]

  • 12. Effect of minor manufacturing changes on stability of compositionally equivalent PLGA microspheres.
    Andhariya JV, Shen J, Wang Y, Choi S, Burgess DJ.
    Int J Pharm; 2019 Jul 20; 566():532-540. PubMed ID: 31181309
    [Abstract] [Full Text] [Related]

  • 13. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load.
    Ravivarapu HB, Lee H, DeLuca PP.
    Pharm Dev Technol; 2000 Jul 20; 5(2):287-96. PubMed ID: 10810758
    [Abstract] [Full Text] [Related]

  • 14. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
    Doty AC, Hirota K, Olsen KF, Sakamoto N, Ackermann R, Feng MR, Wang Y, Choi S, Qu W, Schwendeman A, Schwendeman SP.
    Biomaterials; 2016 Dec 20; 109():88-96. PubMed ID: 27693924
    [Abstract] [Full Text] [Related]

  • 15. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends.
    Wang T, Xue P, Wang A, Yin M, Han J, Tang S, Liang R.
    Eur J Pharm Sci; 2019 Oct 01; 138():104990. PubMed ID: 31302216
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
    Alcalá-Alcalá S, Urbán-Morlán Z, Aguilar-Rosas I, Quintanar-Guerrero D.
    Int J Nanomedicine; 2013 Oct 01; 8():2141-51. PubMed ID: 23788833
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
    Ravivarapu HB, Burton K, DeLuca PP.
    Eur J Pharm Biopharm; 2000 Sep 01; 50(2):263-70. PubMed ID: 10962237
    [Abstract] [Full Text] [Related]

  • 20. Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.
    Liang D, Walker J, Schwendeman PS, Chandrashekar A, Ackermann R, Olsen KF, Beck-Broichsitter M, Schwendeman SP.
    Drug Deliv Transl Res; 2025 Jan 01; 15(1):185-202. PubMed ID: 38643259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.